Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomedical interventions for HIV prevention in MSM in Amsterdam: a demonstration project
2014-002569-32Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Academic Medical Center. Primary endpoint: Uptake of each prevention intervention strategy. Started Apr 2015; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-002569-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002569-32.